Patent · US Active

BCMA specific VCAR compositions and methods for use

US12415844B2 · kind B2 · utility

0Cited by
73References
79Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2018
Grant dateSep 16, 2025
Priority date—
Expiry dateDec 13, 2040

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are VHH chimeric antigen receptors (VCARs), VCAR transposons encoding VCARs of the disclosure, cells modified to express VCARs of the disclosure, as well as methods of making and methods of using the same for adoptive cell therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.